Trial NCT04327934

View at ClinicalTrials.gov 
Org. Study IDs: 2000020950
Secondary IDs: R01HL135089-01A1

Last trial update was posted on 2024-02-02

MeSH Interventions

Ganirelix Methyltestosterone Prolactin Release-Inhibiting Factors Testosterone Testosterone 17 beta-cypionate Testosterone enanthate Testosterone undecanoate

MeSH Conditions

Hypertension Polycystic Ovary Syndrome Syndrome

Other Conditions


Stopping Reasons

Unble to complete all arms of the planned study due to Covid stoppage and difficulty with recruiting and getting enrolled participants to return post Covid.

Limitations And Caveats

Our primary limitation was stoppage due to Covid (our laboratory was forced to close). We also had a very challenging time recruiting subjects when we reopened after the three-month closure under new rules. Subjects who had been enrolled did not return, and new subjects were difficult to recruit. Thus, we were not able to complete all arms of the planned study. We were able to answer our primary questions regarding autonomic function in women with PCOS.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID